- Home
- API vs TRDA Comparison
API vs TRDA Comparison
Compare API & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- API
- TRDA
- Stock Information
- Founded
- API 2013
- TRDA 2016
- Country
- API United States
- TRDA United States
- Employees
- API N/A
- TRDA N/A
- Industry
- API Computer Software: Prepackaged Software
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- API Technology
- TRDA Health Care
- Exchange
- API Nasdaq
- TRDA Nasdaq
- Market Cap
- API 518.0M
- TRDA 502.9M
- IPO Year
- API 2020
- TRDA 2021
- Fundamental
- Price
- API $4.04
- TRDA $8.76
- Analyst Decision
- API Strong Buy
- TRDA Strong Buy
- Analyst Count
- API 1
- TRDA 3
- Target Price
- API $6.00
- TRDA $25.67
- AVG Volume (30 Days)
- API 609.0K
- TRDA 94.7K
- Earning Date
- API 05-21-2025
- TRDA 05-06-2025
- Dividend Yield
- API N/A
- TRDA N/A
- EPS Growth
- API N/A
- TRDA N/A
- EPS
- API N/A
- TRDA 1.68
- Revenue
- API $133,256,000.00
- TRDA $210,782,000.00
- Revenue This Year
- API $6.89
- TRDA N/A
- Revenue Next Year
- API $10.96
- TRDA N/A
- P/E Ratio
- API N/A
- TRDA $5.21
- Revenue Growth
- API N/A
- TRDA 63.38
- 52 Week Low
- API $1.65
- TRDA $8.73
- 52 Week High
- API $6.99
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- API 33.33
- TRDA 24.80
- Support Level
- API $4.52
- TRDA $9.75
- Resistance Level
- API $4.84
- TRDA $10.87
- Average True Range (ATR)
- API 0.29
- TRDA 0.54
- MACD
- API -0.12
- TRDA -0.08
- Stochastic Oscillator
- API 11.64
- TRDA 1.14
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.